Ophthalmology News

Ophthal

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cervantes-Castaneda RAA et al. - Intravitreal bevacizumab is a useful and therapeutically beneficial agent in the treatment of refractory uveitic macular edema. Some patients will require adjunctive intravitreal bevacizumab injections or the use of combination therapy with intravitreal triamcinolone acetonide.

Related Articles

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09    Relevance Score: 69%

Phacoemulsification With Intravitreal Bevacizumab Injection in Diabetic Patients With Macular Edema and Cataract
Retina, 11/20/09    Relevance Score: 68%

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09    Relevance Score: 68%

Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09    Relevance Score: 68%

Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion
American Journal of Ophthalmology, 10/30/09    Relevance Score: 68%